Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.23
Price to sales ratio
1.46

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2086
ATEC
Alphatec Holdings, Inc. - Common Stock
10.67 USD+3.09%+6.91%+1.72%-18.92%1.65 B USD
2226
CNMD
CONMED Corporation Common Stock
44.40 USD-1.60%-4.37%-5.31%-7.40%1.33 B USD
2323
IRMD
iRadimed Corporation - Common Stock
87.45 USD+1.83%+2.52%+5.45%+19.78%1.12 B USD
2333
BVS
Bioventus Inc. - Class A Common Stock
13.07 USD+2.99%-0.38%+0.54%+98.33%1.10 B USD

Frequently asked questions about Tandem Diabetes Care, Inc.

What is the Tandem Diabetes Care, Inc. stock price today?

The current price of Tandem Diabetes Care, Inc. (TNDM) is 16.11. Over the past 24 hours, the stock has changed by +2.74%. Follow the TNDM chart for real-time price dynamics.

What is the stock ticker of Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. trades under the ticker TNDM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tandem Diabetes Care, Inc. stock going up?

TNDM has changed by -2.36% over the last week, -6.23% over the last month, and +7.40% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Tandem Diabetes Care, Inc.?

Tandem Diabetes Care, Inc. currently has a market capitalization of 1.12 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Tandem Diabetes Care, Inc. earnings last quarter?

Last quarter, Tandem Diabetes Care, Inc. reported earnings of -0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Tandem Diabetes Care, Inc. revenue for the last quarter?

Tandem Diabetes Care, Inc. reported quarterly revenue of 254.56 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Tandem Diabetes Care, Inc. net income for the last quarter?

Tandem Diabetes Care, Inc. reported net income of -21.17 M for the last quarter. The previous quarter showed -20.39 M, which means net income changed by -3.80%.

How many employees does Tandem Diabetes Care, Inc. have?

As of the latest available data, Tandem Diabetes Care, Inc. has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.

What is Tandem Diabetes Care, Inc. EBITDA?

Tandem Diabetes Care, Inc. EBITDA is -9.32 M, and its EBITDA margin is -3.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Tandem Diabetes Care, Inc. stock?

You can buy Tandem Diabetes Care, Inc. (TNDM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tandem Diabetes Care, Inc. stock?

Investing in Tandem Diabetes Care, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TNDM chart and related analysis on metatrader.com as part of your research.

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors. Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion.

News